What's new

AMS BioteQ , stock code: (6864-TW)) announced on August 30 that it has signed a distribution contract for its innovative medical material 'SIPSIP Foam Wound Dressing' with a group of medical institutions in Japan, securing its first overseas order.

The board of directors of AMS BioteQ (TPE:6864) approved the appointment of Deputy General Manager Zhang Yiwei.

AMS BioteQ (TPE:6864) will conduct a rights issue of 40 million NT dollars, with the ex-rights date on September 12. The issue price is set at 28 NT dollars per share.

We would like to thank Yoshiaki Tsukamoto, Director of the Japan Bioindustry Association, Tetsu Yamada, Department Head, Yu-Hong Chen, Consultant of the Bioindustry Development Association, and Project Manager Chih-Ling Hsia and Specialist Hsin-Yuan Wang from the Metalworking Center for personally visiting Yuan Zhang.

AMS BioteQ (stock code: 6864-TW) officially signed a distributor contract for the mainland China region with VITAHOUSE PHARAC PTY CO., LIMITED on the 17th of this month. This is an important step for us to capture the China's big health market.

AMS BioteQ (Stock Code: 6864), a biotech company, announced on July 11 that its innovative medical device "SIPSIP Foam Wound Dressing" has successfully obtained the first-class medical device sales permit from Japan's Pharmaceuticals and Medical Devices Agency (PMDA), officially entering the Japanese market.

The National Pharmaceutical Trade Fair (PHARMCHINA) was grandly held in Shanghai, China, from May 15 to 17, 2024. It is a large-scale professional exhibition for health nutrition and wellness products in China.

CPHI Japan was held grandly from April 17 to 19 this year (2024).

In pursuit of academic exchange, fostering industry-academia collaboration, and talent cultivation, the School of Pharmacy at Kaohsiung Medical University and AMS BioteQ recently signed a memorandum of understanding (MOU) to enhance industry-academia exchange, promote the development of the domestic biopharmaceutical industry, and lay the foundation for pharmaceutical research talent cultivation.

The "Connecting with Ukraine" economic revitalization event, orchestrated by the Japan International Cooperation Agency (JICA), convened from February 15th to 17th, 2024. This gathering served as a platform uniting businesses, manufacturers, and research institutions from Japan and Ukraine, pooling their resources to aid in the post-war reconstruction endeavors of Ukraine.

On January 18th, AMS BioteQ (TPE: 6864) announced the successful approval of its application for a novel invention patent in Taiwan titled “ARTIFICIAL DRESSING AND USE OF ARTIFICIAL DRESSING FOR PROMOTING WOUND” by the Intellectual Property Office of the Ministry of Economic Affairs, R.O.C.

AMS BioteQ (TPE: 6864) announced on 11th Dec. last year that its innovative medical care product, "SIPSIP Foam," the wound dressing made of its patented bioengineering technology ExtrO, has successfully obtained the registration number issued by the U.S. FDA.